$2.0986
0.0886[4.41%]
Last update: 6:30PM Get Real Time Here
ProQR Therapeutics
(NASDAQ:PRQR)Latest News for ProQR Therapeutics Stock (NASDAQ:PRQR)
ProQR Therapeutics Stock (NASDAQ: PRQR)
Categories: All
Monday, April 22, 2024
Friday, April 19, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
- ProQR Therapeutics shares are trading higher after the company reported a year-over-year increase in FY23 EPS results.Benzinga Newsdesk - Mar 13, 2024, 3:16PM
- ProQR Therapeutics' 2023 Cash And Cash Equivalents Of €118.9M Is Expected To Provide Cash Runway Into Mid-2026Benzinga Newsdesk - Mar 13, 2024, 7:10AM
- ProQR Therapeutics FY EPS $(0.38) Up From $(0.97) YoYBenzinga Newsdesk - Mar 13, 2024, 7:09AM
Thursday, February 15, 2024
Friday, January 19, 2024
- ProQR Therapeutics Highlights New Platform Data From Presentation On Axiomer RNA Editing Technology, Company Says Platform Demonstrates Robust In Vivo Editing Capabilities Reporting Up To 70% Editing Of ACTB In Liver Of Non-human Primates (NHPS) And MiceBenzinga Newsdesk - Jan 19, 2024, 7:12AM
- ProQR Highlights New Platform Data from Presentation on Axiomer RNA Editing Technology at Deaminet 2024Benzinga Newsdesk - Jan 19, 2024, 7:05AM
Thursday, January 18, 2024
Wednesday, January 17, 2024
Friday, January 05, 2024
Friday, December 08, 2023
Monday, November 27, 2023
Wednesday, November 08, 2023
- Bluebird Bio To Rally Around 267%? Here Are 10 Top Analyst Forecasts For WednesdayLisa Levin - Nov 8, 2023, 7:30AM
- Raymond James Maintains Outperform on ProQR Therapeutics, Lowers Price Target to $4Benzinga Newsdesk - Nov 8, 2023, 6:18AM
- Chardan Capital Upgrades ProQR Therapeutics to Buy, Announces $2 Price TargetBenzinga Newsdesk - Nov 8, 2023, 5:19AM
Monday, September 18, 2023
Monday, August 07, 2023
Friday, August 04, 2023
Wednesday, May 17, 2023
- Cantor Fitzgerald Maintains Overweight on ProQR Therapeutics, Lowers Price Target to $4.5Benzinga Newsdesk - May 17, 2023, 9:51AM
- Analyst Ratings for ProQR TherapeuticsBenzinga Insights - May 17, 2023, 9:01AM
- JMP Securities Reiterates Market Outperform on ProQR Therapeutics, Maintains $6 Price TargetBenzinga Newsdesk - May 17, 2023, 8:47AM
- HC Wainwright & Co. Reiterates Buy on ProQR Therapeutics, Maintains $5 Price TargetBenzinga Newsdesk - May 17, 2023, 6:26AM
Tuesday, May 16, 2023
Thursday, March 30, 2023
- Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Mar 30, 2023, 12:43PM
- JMP Securities Reiterates Market Outperform on ProQR Therapeutics, Maintains $6 Price TargetBenzinga Newsdesk - Mar 30, 2023, 9:11AM
- Why Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving PremarketLisa Levin - Mar 30, 2023, 7:55AM
- HC Wainwright & Co. Maintains Buy on ProQR Therapeutics, Raises Price Target to $5Benzinga Newsdesk - Mar 30, 2023, 6:24AM
Wednesday, March 29, 2023
- ProQR Therapeutics Filed Prospectus Relates To Resale Of Up To 13.4M Shares By Selling ShareholdersCharles Gross - Mar 29, 2023, 5:00PM
- ProQR Therapeutics Sent Request To SEC For Withdrawal Of Registration Statement On Form F-3Charles Gross - Mar 29, 2023, 4:57PM
- S&P 500 Up 1%; Bluebird Bio Shares PlummetLisa Levin - Mar 29, 2023, 2:56PM
- Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Mar 29, 2023, 12:50PM
- Nasdaq Rises 1%; US Pending Home Sales Increase In FebruaryLisa Levin - Mar 29, 2023, 12:13PM
- US Stocks Open Higher, Dow Jumps Over 200 PointsLisa Levin - Mar 29, 2023, 9:53AM
- Earnings Scheduled For March 29, 2023Benzinga Insights - Mar 29, 2023, 8:20AM
- ProQR Held Cash & Cash Equivalents Of €94.8M, With Cash Runway Expected To Fund Operations Into Mid-2026Benzinga Newsdesk - Mar 29, 2023, 8:04AM
- ProQR Therapeutics FY EPS €(0.91) Up From €(0.96) YoYBenzinga Newsdesk - Mar 29, 2023, 8:02AM
Tuesday, March 28, 2023
Friday, December 23, 2022
Thursday, December 22, 2022
- Cantor Fitzgerald Upgrades ProQR Therapeutics to Overweight, Raises Price Target to $5Benzinga Newsdesk - Dec 22, 2022, 2:45PM
- Dow Dips 600 Points; AMC Entertainment Shares PlungeLisa Levin - Dec 22, 2022, 2:33PM
- Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Dec 22, 2022, 1:13PM
- Nasdaq Down Over 3%; IsoPlexis Shares Spike HigherLisa Levin - Dec 22, 2022, 12:28PM
- Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3Lisa Levin - Dec 22, 2022, 10:13AM
- ProQR shares are trading higher after the company, along with Eli Lilly, announced the expansion of their licensing and collaboration agreement of new genetic medicines. ProQR will receive an upfront payment of $75 million, plus an equity investment.Benzinga Newsdesk - Dec 22, 2022, 9:03AM